Acyclic Carbon To Carbon Unsaturation Patents (Class 514/701)
-
Patent number: 11253493Abstract: Described herein are compositions comprising activators of TRP and ASIC channels that may be useful to improve or preserve exercise performance and exercise recovery.Type: GrantFiled: January 23, 2018Date of Patent: February 22, 2022Assignee: Cliff-Cartwright CorporationInventors: Christoph Westphal, Thomas Wessel
-
Patent number: 10519472Abstract: A cell may include heterologous polynucleotides encoding a multienzyme complex involved in the metabolic pathway of phenylpropanoids and biosynthesis of a vanilloid or a hydroxybenzaldehyde precursor thereof, which multienzyme complex comprises enzymes for the biosynthesis of coumaric acid and a crotonase.Type: GrantFiled: December 30, 2013Date of Patent: December 31, 2019Assignee: RHODIA OPERATIONSInventors: Odile Ramaen, Vincent Sauveplane, Rudy Pandjaitan
-
Publication number: 20150139918Abstract: A mixtures which contain (a) at least one phenylalkenal of formula (I) wherein R1 and R2 independently represent hydrogen, a methyl or phenyl group, R3 represents hydrogen, a phenyl group, alkenyl group or a linear or branched alkyl group with 1 to 5 carbon atoms, and the broken double lines independently represent a single bond or a double bond, and (b) at least one physiological cooling agent.Type: ApplicationFiled: April 18, 2013Publication date: May 21, 2015Inventors: Rita Lages, Hubert Loges, Arnold Machinek, Gabriele Neuendorff, Erich Dilk, Heiko Oertling
-
Patent number: 9034918Abstract: The present invention relates to a composition, in particular an antibacterial drug, including trans-cinnamaldehyde, a pharmaceutical composition including trans-cinnamaldehyde for treatment or prevention, in particular, of a nosocomial infection, specifically caused by a bacteria resistant to anti-bacterial drugs, the use of trans-cinnamaldehyde as an anti-bacterial agent and a method for preparing a surface including the application of a composition according to the invention.Type: GrantFiled: June 7, 2010Date of Patent: May 19, 2015Assignee: SEPTEOSInventor: Nicolas Tesse
-
Publication number: 20150038576Abstract: A composition includes a liquid. The liquid aerosolizes for delivery to a user by an airway. The liquid includes an agent that activates a TRPV3 channel. The agent includes a terpenoid compound.Type: ApplicationFiled: August 1, 2014Publication date: February 5, 2015Applicant: SENTIENS, LLCInventors: Inna S. Timokhina, Reid von Borstel, Dennis Tan, John Siverling
-
Publication number: 20140323583Abstract: The present invention relates to agricultural emulsion concentrates which form stable oil-in-water emulsions when diluted with water. More specifically, the invention relates to stable oil-in-water emulsions which include cinnamaldehyde and diallyl disulfide with a Calsogen® EH and Surfonic® CO 36 emulsion system. The increased stability of the emulsion allows for efficient mixing of the emulsion ingredients and effective storage and application of the cinnamaldehyde and diallyl disulfide to areas in need of nematode protection or treatment.Type: ApplicationFiled: July 9, 2014Publication date: October 30, 2014Inventors: Benjamin A. Belkind, Bassam Shammo, Rebecca Dickenson, Linda A. Rehberger, Daniel F. Heiman
-
Publication number: 20140314699Abstract: The present invention concerns a compound of formula wherein R represents a hydrogen atom or a C1-2 alkyl or alkoxyl group; each R1, R2 or R3 represents a hydrogen atom or a methyl or ethyl group; and X represents a CHO, COOR4 or CN group, R4 being a methyl or ethyl group; and at least one of said R, R1 or R2 represents a group containing at least one carbon atom; and it use as perfuming ingredient, for instance to impart odor notes of the floral and/or anis type.Type: ApplicationFiled: July 3, 2014Publication date: October 23, 2014Applicant: FIRMENICH SAInventor: Robert MORETTI
-
Patent number: 8835511Abstract: Absorbent articles provided with an odor control system. The odor control system includes at least two classes of odor control materials, wherein one class acts on malodors or a malodorous substance in the absorbent article and a second class acts on nose receptors. The classes of odor control materials may be selected to provide a synergistic effect in terms of malodor reduction.Type: GrantFiled: April 4, 2007Date of Patent: September 16, 2014Assignee: The Procter & Gamble CompanyInventors: Giovanni Carlucci, Antonella Pesce, Mariangela Caputi, Giancarlo Sierri, Alessandro Gagliardini
-
Publication number: 20140242138Abstract: Method for the preparation of microencapsulated essential oils or a formulation thereof for various non-agricultural applications.Type: ApplicationFiled: May 7, 2014Publication date: August 28, 2014Applicant: BOTANOCAP LTD.Inventors: Amnon Kritzman, Arie Markus, Pnina Strongin, Charles Linder
-
Patent number: 8784910Abstract: The present invention provides an antimicrobial composition comprising an antimicrobial effective amount (such as a preservative, bactericidal, and/or fungicidal effective amount) of a mixture comprising at least two of: (a) lemon grass oil; (b) cinnamaldehyde, cinnamon oil, Cinnamomum cassia, cinnamon extract, cassia leaf oil, 3,4-dihydroxycinnamic acid or salt thereof, or a mixture thereof; (c) sorbic acid, or a salt thereof; (d) erythorbic acid, or a salt thereof; (e) benzoic acid, or a salt thereof; (f) arabinogalactan, galactoarabinan, or a mixture thereof; (g) a hexahydro-iso-alpha-acid, tetrahydro-iso-alpha-acid, or a mixture thereof; (h) Achillea fragrantissima (Santolina fragrantissima Forssk., lavender cotton) oil; and (i) ?-gluconolactone. The present invention also provides a product (preferably a product other than a foodstuff, pharmaceutical, or cosmetic) comprising a preservative effective amount of cinnamaldehyde or a mixture of cinnamaldehyde and one or more alkanol-dialkyl hydantoins.Type: GrantFiled: March 11, 2009Date of Patent: July 22, 2014Assignee: Lonza Inc.Inventors: Patrick Jay Lutz, Olga Borokhov, Abraham Shibu
-
Patent number: 8779003Abstract: Disclosed herein is a method for prolonging analgesic effect of a membrane permeable local anesthetic in a subject in need thereof. The method uses cinnamaldehyde as an adjuvant which, when administered prior to or simultaneously with the administration of a local anesthetic, prolongs the analgesic effect of the local anesthetic. Also disclosed herein is a method for providing analgesic effect in a subject in need thereof. The method uses cinnamaldehyde as an analgesic compound which, when administered alone to the subject in an analgesically effective amount, provides the analgesic effect.Type: GrantFiled: December 29, 2011Date of Patent: July 15, 2014Assignee: Mackay Memorial HospitalInventor: Yu-Chun Hung
-
Publication number: 20140088185Abstract: A buccally administered dosage for assisting with the relief of common digestive complaints where the dosage formed into a hard candy dosage drop, where the dosage is a sugar base infused with a botanical derivative that has concentrated active compositions in sufficient concentration to provide a soothing effect of digestive upset, and where the drop has favorable organoleptic properties.Type: ApplicationFiled: November 27, 2013Publication date: March 27, 2014Inventors: Dustin Garth James, Helen Kim-James
-
Publication number: 20140056983Abstract: The invention concerns a composition based on a mixture of eugenol and cinnamaldehyde, as food additive for feeding ruminants. The composition may be incorporated in a food additive or a salt block. The eugenol and the cinnamaldehyde may be natural or identical natural constituents. Administering the composition of the food additive increases meat production and milk production.Type: ApplicationFiled: October 7, 2013Publication date: February 27, 2014Applicants: ADM Alliance Nutrition, Inc., AXIS FRANCE S.A.S.Inventors: Francois Gautier, Christopher Kamel, Sergio Calsamiglia, Perry Doane
-
Publication number: 20130324597Abstract: This invention pertains to an anti-microbial, in particular anti-bacterial, more particularly against Gram?bacteria, and/or anti-fungal composition comprising as active blend trans-cinnamaldehyde and a potentiating agent, and to the potentiating agent. In particular this composition is intended for preventing and/or treating microbial infection in an animal.Type: ApplicationFiled: December 9, 2011Publication date: December 5, 2013Applicant: SEPTEOSInventor: Nicolas Tesse
-
Patent number: 8586635Abstract: The present invention is related to an antifungal composition for the inhibition of wood decay caused by wood rot fungi. The invention further comprises a method for the inhibition of wood decay with gallates.Type: GrantFiled: August 17, 2011Date of Patent: November 19, 2013Assignee: National Taiwan UniversityInventors: Shang-Tzen Chang, Fu-Lan Hsu, Hui-Ting Chang, Tsair-Bor Yen
-
Publication number: 20130296422Abstract: Novel compounds below are useful for preventing or treating diseases caused by protozoans. At least one of a compound represented by Formula (I) (wherein, X represents a hydrogen atom or a halogen atom; R1 represents a hydrogen atom; R2 represents a hydrogen atom or a C1-7 alkyl group; R3 represents —CHO, —C(?O)R5, —COOR5 (wherein R5 represents a C1-7 alkyl group), —CH2OH or —COOH; and R4 represents a C1-16 alkyl group having one or more substituents on a terminal carbon atom and/or non-terminal carbon atom(s), a C2-16 alkenyl group having one or more substituents on a terminal carbon atom and/or non-terminal carbon atom(s), or a C2-16 alkynyl group having one or more substituents on a terminal carbon atom and/or non-terminal carbon atom(s)), an optical isomer thereof, and a pharmaceutically acceptable salt is used.Type: ApplicationFiled: November 1, 2011Publication date: November 7, 2013Applicant: ARIGEN PHARMACEUTICALS, INC.Inventors: Hiroyuki Saimoto, Kiyoshi Kita, Yoshisada Yabu, Masaichi Yamamoto
-
Publication number: 20130289103Abstract: This invention pertains to an anti-microbial, in particular anti-bacterial and/or anti-fungal composition comprising cinnamaldehyde, trans-2-methoxy cinnamaldehyde, cinnamyl acetate and linalool. In particular this composition is intended for preventing and/or treating microbial infection in an animal.Type: ApplicationFiled: December 9, 2011Publication date: October 31, 2013Applicant: SEPTEOSInventor: Nicolas Tesse
-
Publication number: 20130281411Abstract: Compositions are disclosed that contain an effective inflammatory-dermatological disease-treating or condition-treating active agent and a pharmaceutically-acceptable carrier or vehicle. Methods of using the compositions to treat a subject's skin are also disclosed.Type: ApplicationFiled: June 17, 2013Publication date: October 24, 2013Inventor: Bryan B. Fuller
-
Publication number: 20130196950Abstract: Compositions of and methods for using synthetic retinoids as retinoid replacements and opsin agonists are provided.Type: ApplicationFiled: December 7, 2012Publication date: August 1, 2013Applicant: University Of WashingtonInventor: University of Washingon
-
Publication number: 20130172387Abstract: Disclosed herein is a method for prolonging analgesic effect of a membrane permeable local anesthetic in a subject in need thereof. The method uses cinnamaldehyde as an adjuvant which, when administered prior to or simultaneously with the administration of a local anesthetic, prolongs the analgesic effect of the local anesthetic. Also disclosed herein is a method for providing analgesic effect in a subject in need thereof. The method uses cinnamaldehyde as an analgesic compound which, when administered alone to the subject in an analgesically effective amount, provides the analgesic effect.Type: ApplicationFiled: December 29, 2011Publication date: July 4, 2013Inventor: Yu-Chun HUNG
-
Patent number: 8367736Abstract: Disclosed herein is an anticancer composition, comprising obovatol, represented by the following Chemical Formula 1, obovatal, represented by the following Chemical Formula 2, and/or pharmaceutical salts thereof. The composition exhibits the activity of inhibiting the growth of cancer cells and suppressing the expression and activity of matrix metalloproteinases (MMPs), and thus can be useful for the prophylaxis and treatment of cancer as well as for the inhibition of cancer metastasis.Type: GrantFiled: August 19, 2008Date of Patent: February 5, 2013Assignee: Korea Research Institute of Bioscience and BiotechnologyInventors: Byoung-Mog Kwon, Kwang-Hee Son, Dong-Cho Han, Su-Kyung Lee, Jung-Min Kim, Young-Hee Kho, Hyo-Kon Chun, Jae-Young Yang
-
Patent number: 8268895Abstract: The present invention concerns the use as perfuming ingredient, for instance to impart odor notes of the floral and/or green type, of a compound of formula 5 wherein R is an ortho, meta or para substituent of the phenyl, and represents a hydrogen atom or a C 1-2 alkyl or alkoxyl group; R 1 represents a hydrogen atom or a methyl or ethyl group; 10 R 2 represents a hydrogen atom or a C 1-3 alkyl group; and X represents a CHO, COOR 3, CH(OR 4) 2 or CN group, R 3 being a methyl or ethyl group, and R 4, taken seperately, being a methyl or ethyl group, or said R 4, taken together, a C 2-5 alkanediyl group; and at least one of said R, R 1 or R 2 represents a group containing at least one carbon atom.Type: GrantFiled: November 3, 2009Date of Patent: September 18, 2012Assignee: Firmenich SAInventor: Robert Moretti
-
Publication number: 20120225109Abstract: A formulation to reduce the numbers of bacteria, particularly Gram positive bacteria, in a space such as a waste disposal bin, via the vapor phase, and active over a long period, typically several weeks. The product comprises one or more essential oils or essential oil components plus a mixture of volatile and non-volatile solvents, on a carrier such as a non-woven, sintered plastic or cardboard.Type: ApplicationFiled: March 9, 2012Publication date: September 6, 2012Inventors: Philip Caunt, Deborah Williams
-
Publication number: 20120148690Abstract: A novel skin barrier function recovery acceleration method and accelerator are provided. The present invention provides a skin barrier function recovery accelerator that comprises a TRPA1 agonist capable of activating TRPA1 in epidermal cells.Type: ApplicationFiled: December 10, 2010Publication date: June 14, 2012Inventors: Mitsuhiro Denda, Moe Tsutsumi, Sumiko Denda
-
Publication number: 20120077875Abstract: The present invention relates to a composition, in particular an antibacterial drug, including trans-cinnamaldehyde, a pharmaceutical composition including trans-cinnamaldehyde for treatment or prevention, in particular, of a nosocomial infection, specifically caused by a bacteria resistant to anti-bacterial drugs, the use of trans-cinnamaldehyde as an anti-bacterial agent and a method for preparing a surface including the application of a composition according to the invention.Type: ApplicationFiled: June 7, 2010Publication date: March 29, 2012Applicant: SEPTEOSInventor: Nicolas Tesse
-
Publication number: 20120070422Abstract: A method wherein subjects having or at risk for having hyperopia, presbyopia or astigmatism are administered a composition having an effective amount of ocular antioxidants, including specifically macular pigments, to prevent, treat, or delay the onset of age-related macular degeneration (AMD).Type: ApplicationFiled: September 21, 2011Publication date: March 22, 2012Applicant: KEMIN INDUSTRIES, INC.Inventor: Richard Roberts
-
Publication number: 20120034313Abstract: A chemical blend that simultaneously kills bacteria and suppresses the production of hydrogen sulfide (H2S) includes both a first chemical, which may be a glutaraldehyde, a tetrakishydroxymethyl phosphonium sulfate (THPS), a quaternary amine compound, a thiocyanate, a carbamate, a cinnamaldehyde, an alkyl dimethyl benzyl ammonium chloride, and/or a diamine diacetate; a second chemical which is a quinone; optionally a third chemical, which is a phosphate compound and a solvent which includes monoethylene glycol. The chemical blend has shown synergistic results for killing bacteria and/or suppressing the production of hydrogen sulfide as compared with the addition of the results of each of the components of the blend used separately.Type: ApplicationFiled: March 15, 2011Publication date: February 9, 2012Applicant: Baker Hughes IncorporatedInventors: Jodi Beth Wrangham, Sebastian D. Mancuso
-
Publication number: 20110301246Abstract: The present invention is related to an antifungal composition for the inhibition of wood decay caused by wood rot fungi. The invention further comprises a method for the inhibition of wood decay with gallates.Type: ApplicationFiled: August 17, 2011Publication date: December 8, 2011Applicant: NATIONAL TAIWAN UNIVERSITYInventors: SHANG-TZEN CHANG, FU-LAN HSU, HUI-TING CHANG, TSAIR-BOR YEN
-
Publication number: 20110288168Abstract: Histone deacetylase is a metallo-enzyme with zinc at the active site. Compounds having a zinc-binding moiety, such as, for example, a hydroxamic acid group or a carboxylic acid group, can inhibit histone deacetylase. Histone deacetylase inhibition can repress gene expression, including expression of genes related to tumor suppression. Accordingly, inhibition of histone deacetylase can provide an alternate route for treating cancer, hematological disorders, e.g., hemoglobinopathies, genetic disorders, e.g. Huntington's disease and spinal muscular atrophy and genetic related metabolic disorders, e.g., cystic fibrosis and adrenoleukodystrophy.Type: ApplicationFiled: November 29, 2010Publication date: November 24, 2011Inventors: Hsuan-Yin Lan-Hargest, Robert J. Kaufman, Norbert L. Wiech
-
Publication number: 20110281949Abstract: Use of alkyl phenol and monocyclic monoterpene-derived compounds in the treatment of neuronal damage and in inhibiting activity of TRPC and non-thermo-TRPM channels, and use of bicyclic monoterpene-derived compounds in activating TRPC and non-thermo-TRPM channels.Type: ApplicationFiled: February 3, 2011Publication date: November 17, 2011Inventors: Baruch Minke, Moshe Parnas
-
Publication number: 20110274677Abstract: An organic pest control product comprising nutmeg oil and D-limonene is disclosed. In some embodiments the organic pest control product further comprises a miscibility enhancer to enhance the effectiveness of the product. In some embodiments the miscibility enhancer can comprise a liquid soap or detergent. Additional formulations that comprise cassia oil and/or eucalyptus oil are also disclosed. A method of use of an organic pest control product is also disclosed, in which the organic pest control product is effective to control a wide range of biological pests including fungi, bacteria, and insects, including those responsible for Dutch Elm Disease, fire blight, and Colony Collapse Disorder.Type: ApplicationFiled: October 31, 2008Publication date: November 10, 2011Inventors: Bob Mullen, Linda Louise Mullen
-
Publication number: 20110263696Abstract: Compositions comprising proanthocyanidin compositions (e.g. those extracted from cinnamomum species) that are observed to bind tau and inhibit its aggregation as well as methods for making and using such compositions are disclosed. In certain embodiments of the invention, the proanthocyanidins can be used as a probe to identify and/or characterize tau isoforms in a variety of contexts. In other embodiments of the invention, these compositions are used in methods designed to treat neurological disorders associated with tau aggregation (e.g. Alzheimer's disease).Type: ApplicationFiled: March 31, 2008Publication date: October 27, 2011Inventors: Donald J. Graves, John Lew
-
Publication number: 20110257266Abstract: Disclosed herein are therapeutic regimens for treating or ameliorating a visual disorder associate with an endogenous retinoid deficiency in a subject by administering a therapeutically effective amount of a synthetic retinal derivative or a pharmaceutically acceptable composition comprising a synthetic retinal derivative according to the therapeutic regimen which leads to local recovery of visual functions such as visual fields, visual acuity and retinal sensitivity, among others.Type: ApplicationFiled: April 19, 2011Publication date: October 20, 2011Applicant: QLT, INC.Inventors: H. Andrew Strong, Suzanne Cadden
-
Publication number: 20110195938Abstract: Biofouling may be prevented or at least mitigated by employing a cinnamaldehyde additive to augment the affect of the conventional biocide. Exemplary cinnamaldehyde additives include, but are not limited to, cinnamaldehyde, cinnamic acid and cinnamyl alcohol. A cinnamaldehyde additive by itself, in some applications, may also inhibit biofouling.Type: ApplicationFiled: February 2, 2011Publication date: August 11, 2011Applicant: Baker Hughes IncorporatedInventors: Kenneth G. Wunch, Joseph E. Penkala
-
Publication number: 20110152373Abstract: The present invention provides a new pharmaceutical application of a 15,15-difluoroprostaglandin F2? derivative. As a result of intensive studies in order to find a new pharmaceutical application of a 15,15-difluoroprostaglandin F2? derivative, it was found that, in a European Phase III clinical trial for tafluprost, one of the 15,15-difluoroprostaglandin F2? derivatives, with patients with open-angle glaucoma or ocular hypertension, tafluprost has actions of growing eyelashes, making eyelashes thicker, and changing the color thereof, that is, has an effect of promoting the growth of hair (eyelashes). Therefore, a 15,15-difluoroprostaglandin F2? derivative is useful as a hair growth promoting agent, and is expected to be useful as an active ingredient of a preventive or therapeutic agent for a disease associated with hair such as alopecia and a hair care product or a hair cosmetic product for regrowing hair, growing hair, increasing hair density, nourishing hair, or the like.Type: ApplicationFiled: September 4, 2009Publication date: June 23, 2011Applicant: SANTAN PHARMACEUTICAL CO., LTD.Inventor: Auli Ropo
-
Patent number: 7956092Abstract: A non-toxic insecticidal composition includes a base horticultural oil, an emulsifier such as potassium salts of fatty acids, cinnamaldehyde and eugenol.Type: GrantFiled: April 11, 2008Date of Patent: June 7, 2011Assignee: Alberta Innovates—Technology FuturesInventors: Cathy Knoblauch, Ken Fry
-
Publication number: 20110092591Abstract: The present invention is related to a family of phenyl-prenyl derivatives of formula (I), and to their use in the treatment of cognitive, neurodegenerative or neuronal diseases or disorders, such as Alzheimer's disease or Parkinson's Disease. The present invention also relates to pharmaceutical compositions comprising the same. Further, the present invention is directed to the compounds of formula (I) for medical use, particularly for the use for the treatment and/or prevention of a cognitive, neurodegenerative or neuronal disease or disorder, and to the use of the compounds in the manufacture of a medicament for the treatment and/or prevention of a cognitive, neurodegenerative or neuronal disease or disorder.Type: ApplicationFiled: February 6, 2009Publication date: April 21, 2011Applicant: NOSCIRA S.A.Inventors: Javier Lopez Ogalla, Pilar Munoz Ruiz, Diana Alonso Gordillo, Miguel Medina Padilla, Esther Garcia Palomero, Ana Martinez Gil, Ana Castro Morera
-
Publication number: 20110052727Abstract: The invention presents nutritional supplements with anti influenza activities. In a preferred embodiment, the invention features administration to a subject an effective dose of a nutritional supplement that includes a combination of all or some of the following ingredients licorice, quercetin, green tea, cinnamon, propolis, and selenium.Type: ApplicationFiled: August 31, 2009Publication date: March 3, 2011Inventor: Hanan Polansky
-
Publication number: 20100249244Abstract: The presently claimed and disclosed inventive concept(s) contemplates compositions comprising compounds, in particular dihydroeugenol (DHE) and/or isoeugenol (IE) and/or ethyl vanillin (EV) or salts, esters, ethers, or derivatives thereof, and methods for topically or systemically delivering them for treatment against inflammation-related and other dermatological conditions such as described herein. These DHE and/or IE and/or EV or salts, esters, ethers or derivatives thereof also are delivered to a measurable extent transepidermally or transdermally.Type: ApplicationFiled: March 31, 2010Publication date: September 30, 2010Inventor: Bryan B. Fuller
-
Publication number: 20100215775Abstract: The invention relates to the use of C10-C14-alkane-1,2-diols, in particular 1,2-decanediol, 1,2-dodecanediol and/or 1,2-tetradecanediol, in the preparation of a composition for the prophylaxis and/or treatment of Malassezia-induced dandruff formation, as well as to cosmetic and/or dermatological preparations comprising C10-C14-alkane-1,2-diols.Type: ApplicationFiled: October 12, 2007Publication date: August 26, 2010Applicant: SYMRISE GmbH & Co. KGInventors: Gerhard Schmaus, Sabine Lange
-
Publication number: 20100178364Abstract: The invention presents methods for decreasing the concentration of a foreign polynucleotide in a human or animal subject, especially, when such polynucleotide is latent in the subject.Type: ApplicationFiled: January 12, 2009Publication date: July 15, 2010Inventor: Hanan Polansky
-
Publication number: 20100168045Abstract: The invention concerns novel polyunsaturated compounds of formula (I) wherein: R1 represents a R?1, -A-R?1 group, R?1 being selected from —COOH, —COOR3, —CONH2, —CONHR3, —CONR3, R4, —CHO, —CH2OH, —CH2OR5, and A represents a C2-C16 alkylene, alkenylene or alkynylene; R2 represents: an optionally substituted aryl group or an optionally substituted heteroaryl group; a sugar residue or, a fatty acid residue optionally branched and/or substituted preferably at the chain terminus and particularly by hydroxy, acetoxy radical or by an optionally protected amino radical; a —OC—(CH2)n CO-tocopheryl (alpha, beta or gamma or delta) group, with 2 $m(F) n $m(F) 10; a —R?2—O—R6 group, wherein R?2 is an optionally substituted arylene group or an optionally substituted heteroarylene group, and R6 represents a hydrogen atom, a straight or branched optionally substituted C1-C16 alkyl, a straight or branched optionally substituted C2-C16 alkenyl, or a straight or branched C2-C16 alkynyl group, an optionally substituted tocopheryType: ApplicationFiled: December 14, 2006Publication date: July 1, 2010Applicant: Pierre Fabre Dermo-CosmetiqueInventors: Pascal Bordat, Roger Tarroux, Jean-Hilaire Saurat, Olivier Sorg, Jean-Louis Brayer, Natacha Frison
-
Publication number: 20100120911Abstract: Disclosed is a novel method for preserving cosmetic/personal care formulations through a two component preservative system, said system comprising (a) Component I which functions to eliminate the existing microbial contamination load in a natural cosmetic formulation base through an optimized pasteurization method that avoids deep freezing; and (b) Component II that includes the step of adding synergistic blends of fractionated essential oils, extracts and isolated compounds to the pre-pasteurized cosmetic base obtained through the method of component I, wherein the synergistic blends sustain the effects of pasteurization through anti-microbial and anti-oxidant effects, said anti-oxidant effects enhancing further the anti-microbial effects by virtue of inhibiting lipid per oxidation that facilitates the undue proliferation of microbe.Type: ApplicationFiled: May 4, 2009Publication date: May 13, 2010Inventors: Muhammed Majeed, Beena Bhat, Garima Agarwal
-
Publication number: 20100099777Abstract: The invention generally relates to mixtures of cinnamaldehyde (cinnamic aldehyde) and allicin (10%) in emulsifiable suspension formulations at ratios ranging from 1:1 to 20:1 for protecting plants from damage by nematodes, fungal pathogens, insects and mites. The nematicidal compositions described are easily flowable, easily mixable in water and have low volatility and exhibit no phytotoxicity. Methods of applying the compositions for agriculture use are disclosed.Type: ApplicationFiled: October 16, 2009Publication date: April 22, 2010Inventors: Bala N. DEVISETTY, Bassam SHAMMO, Linda A. REHBERGER, Rebecca DICKENSON, Heemanshubhai K. PATEL, Daniel F. HEIMAN
-
Publication number: 20100048686Abstract: It is an object of the present invention to discover that a perfume can change a person's temperature sense and humidity sense, to identify a perfume component that can change temperature sense, and to provide a perfume composition for controlling temperature sense that contains this perfume component, and to a sense control method or sense control article such as an aromatic or a cosmetic that is beneficial for controlling temperature sense, and to a perfume map for selecting a perfume suited to controlling temperature sense. The perfume composition is characterized in that a perfume component that changes the temperature subjectively sensed by a person (temperature sense) is contained, and that the perfume component that changes the temperature sense is a perfume component identified on the basis of a temperature image obtained from test subject assessment.Type: ApplicationFiled: August 24, 2009Publication date: February 25, 2010Applicant: SHISEIDO CO., LTD.Inventors: Ken Shoji, Sumie Taguchi, Yushi Terajima
-
Publication number: 20090325972Abstract: Disclosed herein are a novel cinnamaldehyde compound represented by Chemical Formula 1 or pharmaceutically acceptable salts thereof. The cinnamaldehyde compound has improved solubility in water and has inhibitory effects on the growth of cancer cells because it induces cell cycle arrest and cell death. Also disclosed are a method of preparing the cinnamaldehyde compound and an anticancer composition including the compound of Chemical Formula 1.Type: ApplicationFiled: August 28, 2008Publication date: December 31, 2009Applicant: KOREA RESEARCH INSTITUTE OF BIOSCIENCE AND BIOTECHNOLOGYInventors: Byoung Mog KWON, Dong Cho HAN, Hye Nan KIM, Young Min HAN, Dae Seop SHIN, Yeong Rim Kang
-
Publication number: 20090286808Abstract: The present invention provides compositions and methods useful in the treatment and/or prevention of ophthalmic conditions and diseases, such as retinitis pigmentosa, that are dependent upon or related to misfolded opsin proteins in vivo. In addition, screening assays for agents useful in such treatment methods are described.Type: ApplicationFiled: January 21, 2009Publication date: November 19, 2009Applicant: University of Florida Research Foundation, Inc.Inventors: Shalesh Kaushal, Syed M. Noorwez, David A. Ostrov
-
Publication number: 20090258098Abstract: An antifungal composition and penetrating carrier system for topical treatment of dermatophytic infection and secondary bacterial infections. The antifungal composition includes various fungistatic and fungicidal essential oil components, or combinations thereof. The penetrating carrier system may include various ingredients, including a penetration enhancer, such as isopropyl myristate.Type: ApplicationFiled: April 14, 2009Publication date: October 15, 2009Inventors: LANE ROLLING, Craig Oberg, Evan Call
-
Publication number: 20090258950Abstract: A non-toxic insecticidal composition includes a base horticultural oil, an emulsifier such as potassium salts of fatty acids, cinnamaldehyde and eugenol.Type: ApplicationFiled: April 11, 2008Publication date: October 15, 2009Applicant: ALBERTA RESEARCH COUNCIL INC.Inventor: Cathy KNOBLAUCH
-
Publication number: 20090191289Abstract: The present invention provides an antimicrobial composition comprising an antimicrobial effective amount (such as a preservative, bactericidal, and/or fungicidal effective amount) of a mixture comprising at least two of: (a) lemon grass oil; (b) cinnamaldehyde, cinnamon oil, Cinnamomum cassia, cinnamon extract, cassia leaf oil, 3,4-dihydroxycinnamic acid or salt thereof, or a mixture thereof; (c) sorbic acid, or a salt thereof; (d) erythorbic acid, or a salt thereof; (e) benzoic acid, or a salt thereof; (f) arabinogalactan, galactoarabinan, or a mixture thereof; (g) a hexahydro-iso-alpha-acid, tetrahydro-iso-alpha-acid, or a mixture thereof; (h) Achillea fragrantissima (Santolina fragrantissima Forssk., lavender cotton) oil; and (i) ?-gluconolactone. The present invention also provides a product (preferably a product other than a foodstuff, pharmaceutical, or cosmetic) comprising a preservative effective amount of cinnamaldehyde or a mixture of cinnamaldehyde and one or more alkanol-dialkyl hydantoins.Type: ApplicationFiled: March 11, 2009Publication date: July 30, 2009Applicant: Lonza Inc.Inventors: Patrick Jay Lutz, Olga Borokhov, Shibu Abraham